126 related articles for article (PubMed ID: 16917140)
1. Experimental mouse model of hormonal therapy effects on the postmenopausal mammary gland.
Haslam SZ
Breast Dis; 2005-2006; 24():71-8. PubMed ID: 16917140
[TBL] [Abstract][Full Text] [Related]
2. A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice.
Raafat AM; Hofseth LJ; Li S; Bennett JM; Haslam SZ
Endocrinology; 1999 Jun; 140(6):2570-80. PubMed ID: 10342844
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model.
Raafat AM; Li S; Bennett JM; Hofseth LJ; Haslam SZ
J Cell Physiol; 2001 Apr; 187(1):81-9. PubMed ID: 11241352
[TBL] [Abstract][Full Text] [Related]
4. Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.
Raafat AM; Hofseth LJ; Haslam SZ
Am J Obstet Gynecol; 2001 Feb; 184(3):340-9. PubMed ID: 11228484
[TBL] [Abstract][Full Text] [Related]
5. Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.
Wood CE; Branstetter D; Jacob AP; Cline JM; Register TC; Rohrbach K; Huang LY; Borgerink H; Dougall WC
Breast Cancer Res; 2013; 15(4):R62. PubMed ID: 23938070
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques.
Cline JM; Soderqvist G; von Schoultz E; Skoog L; von Schoultz B
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):93-100. PubMed ID: 8572040
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
8. Hormonal effects on the mammary gland of postmenopausal nonhuman primates.
Cline JM; Wood CE
Breast Dis; 2005-2006; 24():59-70. PubMed ID: 16917139
[TBL] [Abstract][Full Text] [Related]
9. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
11. Estrogen, estrogen plus progestin therapy, and risk of breast cancer.
Colditz GA
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):909s-17s. PubMed ID: 15701886
[TBL] [Abstract][Full Text] [Related]
12. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
13. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
[TBL] [Abstract][Full Text] [Related]
14. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model.
Haslam SZ; Osuch JR; Raafat AM; Hofseth LJ
J Mammary Gland Biol Neoplasia; 2002 Jan; 7(1):93-105. PubMed ID: 12160089
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast.
Hofseth LJ; Raafat AM; Osuch JR; Pathak DR; Slomski CA; Haslam SZ
J Clin Endocrinol Metab; 1999 Dec; 84(12):4559-65. PubMed ID: 10599719
[TBL] [Abstract][Full Text] [Related]
18. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
19. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
20. Proliferative effects of different hormone regimens on mammary glands in ovariectomized rats.
Cirpan T; Iscan O; Terek MC; Ozsener S; Kanit L; Pogun S; Zekioglu O; Yucebilgin S
Eur J Gynaecol Oncol; 2006; 27(3):256-61. PubMed ID: 16800253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
